ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $219,659 | -1.5% | 8,648 | +57.4% | 0.08% | -8.0% |
| Q4 2022 | $222,918 | -11.9% | 5,496 | 0.0% | 0.09% | +3.5% |
| Q1 2022 | $253,000 | -37.5% | 5,496 | -10.0% | 0.08% | -29.8% |
| Q4 2021 | $405,000 | -15.1% | 6,110 | -20.0% | 0.12% | -19.3% |
| Q3 2021 | $477,000 | -24.5% | 7,635 | 0.0% | 0.15% | -23.5% |
| Q2 2021 | $632,000 | +24.9% | 7,635 | 0.0% | 0.20% | +23.3% |
| Q1 2021 | $506,000 | +4.5% | 7,635 | +21.1% | 0.16% | +1.3% |
| Q4 2020 | $484,000 | +82.0% | 6,306 | +2.0% | 0.16% | +55.4% |
| Q3 2020 | $266,000 | +0.4% | 6,184 | +0.9% | 0.10% | -5.6% |
| Q2 2020 | $265,000 | – | 6,126 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
| Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
| M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
| WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
| Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
| Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
| JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
| COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
| Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
| Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |